Cardiovascular disease impacts lives and hinders progress and development
Cardiovascular disease (CVD) affects individual health, quality of life and wellbeing, as well as causing profound individual and societal economic impacts. Its economic impacts are driven by the loss of productive workforce through premature death, absenteeism, limited workforce participation due to disability, and costs levelled at employers by increased healthcare spending and insurance premiums.
The impact on current and potential economic growth and development for individuals and societies make tackling CVD a development issue, not just a health issue. This demands a rethink away from dealing with the downstream costs of CVD, to making upstream investments to prevent CVD and optimise the health of people with CVD.
In this paper we focus on the impact of CVD in nine emerging markets—Brazil, China, Egypt, Mexico, the Philippines, Saudi Arabia, India, South Africa and the United Arab Emirates.
The changes that policymakers can enact to ensure a resilient health system—for NCDs and beyond:
Advocate for a strong primary health system. Strive for universal health coverage, effective primary health infrastructure and integrated care.
Recognise that the causes of and solutions to NCDs are not solely a “health” issue. Engage stakeholders from outside of the health sector to create good living conditions for a thriving population.
Gather the evidence needed to implement effective policy measures-we know what works. Find evidence for return on investment interventions—particularly from countries with similar challenges—and prioritise NCD funding to suit local needs.
Involve the right, diverse, mix of stakeholders. Shape policy interventions with a wide range of stakeholders. Actively involve and use civil society groups and those who have lived experience, to learn from others wherever possible.

